Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team.
Perspectives from the cutting edge of biotech and pharma
Our serialized podcast series delivers highly differentiated insights and intelligence, turning today’s faster-moving trends into tomorrow’s opportunities
Fresh perspective and nuanced, data driven view of the forces shaping U.S. equity markets
Macro and market strategy series – explores the latest financial market and economic developments
Search all podcasts:
Insights
September 2024
As long-promised infrastructure starts to bear fruit, Canada’s energy market is starting to attract serious investor...
In a shifting financial landscape, banks are emerging as compelling value investments, driven by modest GDP growth and...
A few things went right for Small Caps last week and we highlight our current, top-down US equity market read throughs...
Don’t miss this month’s edition of the George Davis Report, where George discusses RBC’s revised Fed call and the...
In today's episode we discuss how election uncertainty has persisted with policy getting greater attention from both...
As we return from the Labor Day holiday weekend in the US, we find that major challenges for US equities are still...
Can AI and machine learning make the drug discovery process faster? In this episode of Pathfinders in Biopharma, Noël...
August 2024
In today's podcast, we highlight a few of the most interesting charts in our deck on earnings right now. Listen now.
RBC’s fintech and payments analyst explains how the sector has evolved and explores current market trends in this...
Get the latest insights from RBC Capital Markets delivered to your inbox.